NCT04053868View on ClinicalTrials.gov

Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions

Nicotine Administration & DosageE-cigarettesVapingE-LiquidTobacco Smoking

Interventions

OTHER

JUUL

Electronic Cigarette

OTHER

Tobacco

Tobacco Cigarette

Trial Locations (2)

94110

Zuckerberg San Francisco General Hospital, San Francisco

94143

University of California, San Francisco, San Francisco

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of California, San Francisco

OTHER

NCT04053868 - Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes | Biotech Hunter | Biotech Hunter